Green Biologics Awarded £560,000 for Cellulosic Biobutanol Development

Green Biologics (GBL), an Oxfordshire (UK) biotechnology company, has received £560,000 (US$1.1 million) in funding to support the development of its fuel biobutanol product—Butafuel—from cellulosic biomass. The Department of Trade and Industry-led Technology Program is providing £250,000 (US$494,000), and shareholder investors and business angels are providing the rest.

Using its library of thermophiles and thermostable enzymes, GBL has isolated a cocktail of thermophilic microorganisms for the rapid enzymatic hydrolysis and release of fermentable sugars from biomass. The company plans to integrate this patented hydrolysis technology with a proprietary butanol fermentation process.

Green Biologics will partner with EKB Technology, a specialist in process technology, to develop the advanced fermentation process for butanol with improved yields.
***
Butanol has a number of attractive properties as a fuel. Its energy content is closer to gasoline than ethanol’s. It is non-corrosive, can be distributed through existing pipelines, and can be—but does not have to be—blended with fossil fuels. Butanol itself could be reformed for hydrogen for use in fuel cells, and the production process itself produces hydrogen.

In June 2006, BP and DuPont recently announced a collaboration with British Sugar to produce biobutanol in the UK. BP provides a route for butanol into the transport fuel market and aims to blend butanol with gasoline at its 1,200 filling stations. (Earlier post.)
***
a little more: http://www.greencarcongress.com/2007/01/green_biologics.html